Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease
Joshua Solomon, Maria Carolina Festa, Yiannis S. Chatzizisis, Ratna Samanta, Rita S. Suri, Thomas A. Mavrakanas
Topics & Concepts
EmpagliflozinCanagliflozinMedicineDapagliflozinKidney diseaseDiabetes mellitusPopulationHeart failureDiseaseInternal medicinePharmacologyType 2 diabetesIntensive care medicineEndocrinologyEnvironmental healthDiabetes Treatment and ManagementPotassium and Related DisordersMetabolism, Diabetes, and Cancer